Literature DB >> 28026208

MRI of Small Hepatocellular Carcinoma: Typical Features Are Less Frequent Below a Size Cutoff of 1.5 cm.

Moon Hyung Choi1, Joon-Il Choi1, Young Joon Lee1, Michael Yong Park1, Sung Eun Rha1, Chandana Lall2.   

Abstract

OBJECTIVE: The purposes of this study were to analyze MRI features of small hepatocellular carcinomas (HCCs) on the basis of size and to evaluate the difference in frequency of typical radiologic hallmarks of HCC (arterial enhancement and washout) according to the tumor size.
MATERIALS AND METHODS: Enrolled were 86 patients with 110 HCCs 3 cm or smaller who underwent surgical resection or transplantation. Two radiologists reviewed gadoxetic acid-enhanced MRI features for signal intensity of T2-weighted and T1-weighted imaging, diffusion restriction, presence of arterial enhancement, washout on portal and transitional phases, and signal intensity on the hepatobiliary phase. ROC curve analysis was performed to determine the optimal HCC cutoff size for radiologic hallmarks of HCC. Tumors were divided into two groups by cutoff size, and the frequencies of MRI features were assessed.
RESULTS: On ROC analysis, the optimal cutoff for radiologic hallmarks of HCC was 1.5 cm in independent and consensus reviews by two radiologists. HCCs smaller than 1.5 cm showed typical finding of HCC less frequently than HCCs 1.5 cm or larger in diameter. In subgroup analyses, HCCs with diameters between 1 and 1.5 cm showed similar MRI findings to HCCs with diameters 1 cm or less but significantly different findings compared with HCCs with diameters from 1.5 to 2 cm and 2-3 cm.
CONCLUSION: HCCs smaller than 1.5 cm in size less frequently showed MRI findings seen typically in larger HCCs. Therefore, small HCCs are harder to detect with certainty not only because of small size but also because of the lower frequency of typical MRI findings.

Entities:  

Keywords:  MRI; diagnostic criteria; gadoxetic acid; hepatic carcinoma

Mesh:

Year:  2016        PMID: 28026208     DOI: 10.2214/AJR.16.16414

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  13 in total

Review 1.  Problematic lesions in cirrhotic liver mimicking hepatocellular carcinoma.

Authors:  Myeong-Jin Kim; Sunyoung Lee; Chansik An
Journal:  Eur Radiol       Date:  2019-02-20       Impact factor: 5.315

2.  Performance of adding hepatobiliary phase image in magnetic resonance imaging for detection of hepatocellular carcinoma: a meta-analysis.

Authors:  Jielin Pan; Wenjuan Li; Lingjing Gu; Chaoran Liu; Ke Zhang; Guobin Hong
Journal:  Eur Radiol       Date:  2022-05-17       Impact factor: 5.315

3.  Evaluation of non-contrast magnetic resonance imaging as an imaging surveillance tool for hepatocellular carcinoma in at-risk patients.

Authors:  Jing Kai Joel Liu; Chau Hung Lee; Cher Heng Tan
Journal:  Singapore Med J       Date:  2020-08-17       Impact factor: 3.331

4.  A Radiomics Nomogram for Preoperative Prediction of Early Recurrence of Small Hepatocellular Carcinoma After Surgical Resection or Radiofrequency Ablation.

Authors:  Liting Wen; Shuping Weng; Chuan Yan; Rongping Ye; Yuemin Zhu; Lili Zhou; Lanmei Gao; Yueming Li
Journal:  Front Oncol       Date:  2021-04-29       Impact factor: 6.244

Review 5.  Major and ancillary magnetic resonance features of LI-RADS to assess HCC: an overview and update.

Authors:  Vincenza Granata; Roberta Fusco; Antonio Avallone; Orlando Catalano; Francesco Filice; Maddalena Leongito; Raffaele Palaia; Francesco Izzo; Antonella Petrillo
Journal:  Infect Agent Cancer       Date:  2017-04-28       Impact factor: 2.965

Review 6.  CT-MRI LI-RADS v2017: A Comprehensive Guide for Beginners.

Authors:  Francesca Patella; Filippo Pesapane; Enrico Maria Fumarola; Ilaria Emili; Riccardo Spairani; Salvatore Alessio Angileri; Silvia Tresoldi; Giuseppe Franceschelli; Gianpaolo Carrafiello
Journal:  J Clin Transl Hepatol       Date:  2018-02-22

7.  Diagnostic value of contrast-enhanced ultrasound versus computed tomography for hepatocellular carcinoma: a retrospective, single-center evaluation of 234 patients.

Authors:  Vincent Schwarze; Constantin Marschner; Wiebke Völckers; Sergio Grosu; Giovanna Negrão de Figueiredo; Johannes Rübenthaler; Dirk-André Clevert
Journal:  J Int Med Res       Date:  2020-06       Impact factor: 1.671

8.  Dynamic Hepatocellular Carcinoma Model Within a Liver Phantom for Multimodality Imaging.

Authors:  Muntaser S Ahmad; Nursakinah Suardi; Ahmad Shukri; Nik Noor Ashikin Nik Ab Razak; Ammar A Oglat; Osama Makhamrah; Hjouj Mohammad
Journal:  Eur J Radiol Open       Date:  2020-09-03

9.  Critical analysis of the major and ancillary imaging features of LI-RADS on 127 proven HCCs evaluated with functional and morphological MRI: Lights and shadows.

Authors:  Vincenza Granata; Roberta Fusco; Antonio Avallone; Francesco Filice; Fabiana Tatangelo; Mauro Piccirillo; Roberto Grassi; Francesco Izzo; Antonella Petrillo
Journal:  Oncotarget       Date:  2017-04-19

10.  Comparison of LI-RADS v.2017 and ESGAR Guidelines Imaging Criteria in HCC Diagnosis Using MRI with Hepatobiliary Contrast Agents.

Authors:  Grzegorz Rosiak; Joanna Podgorska; Edyta Rosiak; Andrzej Cieszanowski
Journal:  Biomed Res Int       Date:  2018-07-15       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.